Hundreds of visitors to cabins at Grand Teton National Park may have been exposed to rabies after bats were found in the area. Health officials are alerting those who stayed in the cabins to seek medical advice immediately.
A deadly outbreak of Legionnaires' disease in New York City's Harlem has resulted in four fatalities, with officials tracing the infection to cooling towers. Health authorities urge residents to seek medical attention if symptoms arise.
A new retrospective study indicates that while GLP-1 receptor agonists for diabetes may slightly increase the risk of new-onset diabetic retinopathy, they also significantly reduce the risk of vision loss. Experts emphasize the importance of regular eye examinations for patients.
President Trump is reviewing the federal classification of marijuana, a potential game-changer for its regulation and taxation. Could this lead to legal changes that reflect state laws?
President Trump hints at reclassifying marijuana as a less dangerous drug, potentially shifting its status from Schedule 1 to Schedule 3. This decision could open doors for research and tax benefits for the cannabis industry.
U.S. health secretary Robert F. Kennedy Jr. calls for the retraction of a Danish study declaring aluminum in vaccines safe. The journal refuses, citing the study's robust data against his claims.
Health Secretary Robert F. Kennedy Jr.'s drastic funding cuts to mRNA vaccine research could stymie medical breakthroughs and push scientific talent away from the U.S., experts warn.
NASA, in collaboration with Google, introduces CMO-DA, an AI medical assistant designed to autonomously diagnose and treat astronauts' health issues during long-duration space missions, such as those to Mars.
Chad Michael Murray reveals a shocking near-death experience that nearly derailed his acting career. Discover how a twisted intestine and a blood transfusion changed his life forever!
Dr. Vinay Prasad is back at the FDA's Center for Biologics Evaluation and Research, raising eyebrows after being ousted amid political turmoil and criticism. His return ignites debates about drug approvals and public health leadership under the Trump administration.
